HLA-typed peripheral blood mononuclear cells (PBMCs) from acute & recovered COVID-19 patients.
Product Description
Specifications
| Size | 10 or 100 million PBMCs |
| Species | Human, SARS-CoV-2 |
| Research Area | Infectious Disease, COVID-19 |
| Shipping Type | Dry ice (additional shipping fee) |
| Cell Number | 10 million, 100 million |
Available samples
E-mail info@raybiotech.com for a list of available samples
Sample Type
Peripheral blood mononuclear cells (PBMCs)
Characterized Markers
Major histocompatibility complex: HLA A, B, and C typed
Anticoagulant
EDTA
Format
Frozen with 10% DMSO
Storage temperature
Store in liquid nitrogen vapor phase
Biosafety Level
2
Note: While the patients were confirmed to have COVID-19 via a test detecting either SARS-CoV-2 virus or viral proteins using a nasopharyngeal swab, the PBMC samples have not been tested for the presence of virus or any other diseases and should be assumed infectious.
Note: While the patients were confirmed to have COVID-19 via a test detecting either SARS-CoV-2 virus or viral proteins using a nasopharyngeal swab, the PBMC samples have not been tested for the presence of virus or any other diseases and should be assumed infectious.


